C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion

Journal of Immunology

Volumn 163, Issue 9, 1999, Pages 5056-5063

  Tas, Sander W ^a   Klickstein, Lloyd B ^b   Barbashov, Sergei F ^a   Nicholson Weller, Anne ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C4B;

ARTICLE; BINDING SITE; COMPLEMENT FIXATION; ERYTHROCYTE ADHESIVENESS; HUMAN; HUMAN TISSUE; IMMUNE ADHERENCE; LIGAND BINDING; PRIORITY JOURNAL; RECEPTOR BINDING;

ANTIGEN-ANTIBODY COMPLEX; CELL ADHESION; COLLAGEN; COMPLEMENT C1; COMPLEMENT C1 INACTIVATOR PROTEINS; COMPLEMENT C1Q; COMPLEMENT C4B; COMPLEMENT SYSTEM PROTEINS; EDETIC ACID; ERYTHROCYTES; HEAT; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN G; KINETICS; LIGANDS; PEPTIDE FRAGMENTS; PROTEIN BINDING; RECEPTORS, COMPLEMENT 3B; TETANUS TOXOID;

EID: 0032711446     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Ahearn, J. M., and A. M. Rosengard. 1998. Complement receptors. In The Human Complement System in Health and Disease. J. E. Volanakis and M. E. Frank, eds. Marcel Dekker, New York, p. 167.
2. Collard, C. D., C. Bukusoglu, A. Agah, S. P. Colgan, W. R. Reenstra, B. P. Morgan, and G. L. Stahl. 1999. Hypoxia-induced expression of complement receptor type 1 (CR1, CD35) in human vascular endothelial cells. Am. J. Physiol. 276:C450.
3. Klickstein, L. B., W. W. Wong, J. A. Smith, J. H. Weis, J. G. Wilson, and D. T. Fearon. 1987. Human C3b/C4b receptor (CR1): demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristic of C3/C4 binding proteins. J. Exp. Med. 165:1095.
4. Klickstein, L. B., T. J. Bartow, B. Miletic, L. D. Rabson, J. A. Smith, and D. T. Fearon. 1988. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis. J. Exp. Med. 168:1699.
5. Krych, M., D. Hourcade, and J. P. Atkinson. 1991. Sites within the complement C3b/C4b receptor important for the specificity of ligand binding. Proc. Natl. Acad. Sci. USA 88:4353.
6. Makrides, S. C., S. M. Scesney, P. J. Ford, K. S. Evans, G. R. Carson, and H. C. J. Marsh. 1992. Cell surface expression of the C3b/C4b receptor (CR1) protects Chinese hamster ovary cells from lysis by human complement. J. Biol. Chem. 267:24754.
7. Klickstein, L. B., S. Barbashov, T. Liu, R. M. Jack, and A. Nicholson-Weller. 1997. Complement receptor type 1 (CR1, CD35) is a receptor for C1q. Immunity 7:345.
8. Nelson, R. A. J. 1953. The immune adherence phenomenon: an immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis. Science 118:733.
9. Cooper, N. R. 1969. Immune adherence by the fourth component of complement. Science 165:396.
10. Fearon, D. T. 1980. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte and monocyte. J. Exp. Med. 152:20.
11. Paccaud, J. P., J. L. Carpentier, and J. A. Schifferli. 1988. Direct evidence of the clustered nature of complement receptors type 1 on the erythrocyte membrane. J. Immunol. 141:3889.
12. Cornacoff, J. B., L. A. Heben, W. L. Smead, M. E. Van Aman, D. J. Birmingham, and F. J. Waxman. 1983. Primate erythrocyte-immune complex-clearing mechanism. J. Clin. Invest. 71:236.
13. Schifferli, J. A., Y. C. Ng, J. Estreicher, and M. J. Walport. 1988. The clearance of tetanus toxoid-anti-tetanus toxoid immune complexes from the circulation of humans: complement-and erythrocyte complement receptor 1-dependent mechanisms. J. Immunol. 140:899.
14. Kimberly, R. P., J. C. Edberg, L. T. Merriam, S. B. Clarkson, J. C. Unkeless, and R. P. Taylor. 1989. In vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzees. J. Clin. Invest. 84:962.
15. Gigli, I., and R. A. Nelson. 1968. Complement dependent immune phagocytosis. Exp. Cell Res. 51:45.
16. Walport, M. J., K. A. Davies, and M. Botto. 1998. C1q and systemic lupus erythematosus. Immunobiology 199:265.
17. Walport, M. J., K. A. Davies, B. J. Morley, and M. Botto. 1997. Complement deficiency and autoimmunity. Ann. NY Acad. Sci. 815:267.
18. Botto, M., C. Dell'Agnola, A. E. Bygrave, E. M. Thompson, H. T. Cook, F. Petry, M. Loos, P. P. Pandolfi, and M. J. Walport. 1998. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19:56.
19. Korb, L. C., and J. M. Aheam. 1997. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes. J. Immunol. 158:4525.
20. Wilson, J. G., W. W. Wong, P. H. Schur, and D. T. Fearon. 1982. Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus. N. Engl. J. Med. 307:981.
21. Knobel, H. R., C. Heusser, M. L. Rodrick, and H. Isliker. 1974. Enzymatic digestion of the first component of human complement (C1q). J. Immunol. 112: 2094.
22. Hammer, C. H., G. H. Wirtz, L. Renfer, H. D. Gresham, and B. F. Tack. 1981. Large scale isolation of functionally active components of the human complement system. J. Biol. Chem. 256:3995.
23. Fearon, D. T., and L. A. Collins. 1983. Increased expression of C3b receptors on polymorphonuclear leukocytes by chemotactic factors and by purification procedures. J. Immunol. 130:370.
24. Arnaout, M. A., J. Melamed, B. F. Tack, and H. R. Colten. 1981. Characterization of the human complement (C3b) receptor with a fluid phase C3b dimer. J. Immunol. 127:1348.
25. Wong, W. W., L. B. Klickstein, J. A. Smith, J. H. Weis, and D. T. Fearon. 1985. Identification of a partial cDNA clone for the human receptor for complement fragments C3b/C4b. Proc. Natl. Acad Sci. USA 82:7711.
26. Diamond, M. S., D. E. Staunton, A. R. de Fourgerolles, S. A. Stacker, J. Garcia-Aguilar, M. L. Hibbs, and T. A. Springer. 1990. ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18). J. Cell Biol. 111:3129.
27. Cullen, D. C., R. G. Brown, and C. R. Lowe. 1987. Detection of immuno-complex formation via surface plasmon resonance on gold-coated diffraction gratings. Biosensors 3:211.
28. Johnsson, B., S. Lofas, and G. Lindquist. 1991. Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors. Anal. Biochem. 198:268.
29. Giclas, P. C. 1992. Complement. In Current Protocols in Immunology, Vol. II. J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. John Wiley & Sons, New York, p. 13.1.19.
30. Paques, E. P., R. Huber, H. Priess, and J. K. Wright. 1979. Isolation of the globular regions of the subcomponent q of the C1 component of complement. Hoppe-Seyler's Z. Physiol. Chem. 360:S177.
31. Lepow, I. H., G. B. Naff, E. W. Todd, J. Pensky, and C. F. J. Hinz. 1963. Chromatographic resolution of the first component of human complement into three activities. J. Exp. Med 117:983.
32. Tenner, A. J., and N. R. Cooper. 1980. Analysis of receptor-mediated C1q binding to human peripheral blood mononuclear cells. J. Immunol. 125:1658.
33. Davis, A. E. I. 1998. C1 inhibitor gene and hereditary angioedema. In The Human Complement System in Health and Disease. J. E. Volanakis and M. M. Frank, eds. Marcel Dekker, New York, p. 455.
34. Ziccardi, R. J., and N. R. Cooper. 1979. Active disassembly of the first complement component, C1, by C1 inactivator. J. Immunol. 123:788.
35. Amaout, M. A., N. Dana, J. Melamed, R. Medicus, and H. R. Colten. 1983. Low ionic strength or chemical cross-linking of monomeric C3b increases its binding affinity to the human complement C3b receptor. Immunology 48:229.
36. Weisman, H. F., T. Bartow, M. K. Leppo, H. C. Marsh, Jr., G. R. Carson, M F. Concino, M. P. Boyle, K. H. Roux, M. L. Weisfeldt, and D. T. Fearon. 1990. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249:146.
37. Wong, W. W., and S. A. Farrell. 1991. Proposed structure of the F′ allotype of human CR1: loss of a C3b binding site may be associated with altered function. J. Immunol. 146:656.
38. Scesney, S. M., S. C. Makrides, M. L. Gosselin, P. J. Ford, B. M. Andrews, E. G. Hayman, and H. C. J. Marsh. 1996. A soluble deletion mutant of the human complement receptor type 1. which lacks the C4b binding site, is a selective inhibitor of the alternative complement pathway. Eur. J. Immunol. 26:1729.
39. Pangburn, M. K. 1986. Differences between the binding sites of the complement regulatory proteins DAF, CR1, and factor H on C3 convertases. J. Immunol. 136:2216.
40. Dickler, H. B., and H. G. Kunkel. 1972. Interaction of aggregated gamma globulin with B lymphocytes. J. Exp. Med. 136:191.
41. Nicholson-Weller, A., and L. B. Klickstein. 1999. C1q binding proteins and C1q receptors. Curr. Opin. Immunol. 11:42.
42. Ruiz, S., A. H. Henschen-Edman, and A. J. Tenner. 1995. Localization of the site on the complement component C1q required for the stimulation of neutrophil superoxide production. J. Biol. Chem. 270:30627.
43. Journet, A., and M. Tosi. 1986. Cloning and sequencing of full-length cDNA encoding the precursor of human complement component C1r. Biochem. J. 240: 783.
44. Leytus, S. P., K. Kurachi, K. S. Sakariassen, and E. W. Davie. 1986. Nucleotide sequence of the cDNA coding for human complement C1r. Biochemistry 25: 4855.
45. Tosi, M., C. Duponchel, T. Meo, and C. Julier. 1987. Complete cDNA sequence of human complement C1s and close physical linkage of the homologous genes C1s and C1r. Biochemistry 26:8516.
46. Reist, D. J., H. Y. Liang, D. Denny, E. N. Martin, W. M. Scheld, and R. P. Taylor. 1994. Cross-linked bispecific monoclonal antibody heteropolymers facilitate the clearance of human IgM from the circulation of squirrel monkeys. Eur. J. Immunol. 24:2018.
47. O'Shea, J. J., E. J. Brown, B. E. Seligmann, J. A. Metcalf, M. M. Frank, and J. I. Galin. 1985. Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils. J. Immunol. 134:2580.
48. Changelian, P. S., R. M. Jack, L. A. Collins, and D. T. Fearon. 1985. PMA induces the ligand-independent internalization of CR1 on human neutrophils. J. Immunol. 134:1851.
49. Nickells, M., R. Hauhart, M. Krych, V. Bala Subramanian, K. Geoghegan-Barek, H. C. J. Marsh, and J. P. Atkinson. 1998. Mapping epitopes for 20 monoclonal antibodies to CR1. Clin. Exp. Immunol. 112:27.
50. 2-Fab chimeric complement inhibitor. J. Exp. Med. 174:1451.
51. Bowness, P., K. A. Davies, P. J. Norsworthy, P. Athanassiou, J. Taylor-Wiedeman, L. K. Borysiewicz, P. A. Meyer, and M. J. Walport. 1994. Hereditary C1q deficiency and systemic lupus erythematosus. Q. J. Med. 87:455.
52. Prodeus, A. P., S. Goerg, L. M. Shen, O. O. Pozdynakova, L. Chu, E. M. Alicot, C. C. Goodnow, and M. C. Carroll. 1998. A critical role for complement in maintenance of self-tolerance. Immunity 9:721.
53. Reid, K. B. M. 1989. Deficiency of the first component of human complement. Immunodefic. Rev. 1:247.
54. Donaldson, V. H., E. V. Hess, and A. J. McAdams. 1977. Lupus-erythematosus-like disease in three unrelated women with hereditary angioneurotic edema. Ann. Intern. Med. 86:312.
55. Brickman, C. M., G. C. Tsokos, J. E. Balow, T. J. Lawley, M. Santaella, C. H. Hammer, and M. M. Frank. 1986. Immunoregulatory disorders associated with hereditary angioedema. I. Clinical manifestations of autoimmune disease. J. Allergy Clin. Immunol. 77:749.
56. Davies, K. A., and M. J. Walport. 1998. Processing and clearance of immune complexes by complement and the role of complement in immune complex diseases. In The Human Complement System in Health and Disease. J. E. Volanakis and M. M. Frank, eds. Marcel Dekker, New York, p. 423.
57. Schifferli, J. A., G. Hauptmann, and J. P. Paccaud. 1987. Complement-mediated adherence of immune complexes to human erythrocytes: difference in the requirements for C4A and C4B. FEBS Lett. 213:415.
58. Gatenby, P. A., J. E. Barbosa, and P. J. Lachmann. 1990. Differences between C4A and C4B in the handling of immune complexes: the enhancement of CR1 binding is more important than the inhibition of immunoprecipitation. Clin. Exp. Immunol. 79:158.